HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fine-tuning vitamin E-containing telodendrimers for efficient delivery of gambogic acid in colon cancer treatment.

Abstract
Certain natural products such as gambogic acid (GA) exhibit potent antitumor effects. Unfortunately, administration of these natural products is limited by their poor solubility in conventional pharmaceutical solvents. In this study, a series of telodendrimers, composed of linear polyethylene glycol (PEG)-blocking-dendritic oligomer of cholic acid (CA) and vitamin E (VE), have been designed with architectures optimized for efficient delivery of GA and other natural anticancer compounds. Two of the telodendrimers with segregated CA and VE domains self-assembled into stable cylindrical and/or spherical nanoparticles (NPs) after being loaded with GA as observed under transmission electron microscopy (TEM), which correlated with the dynamic light scattering (DLS) analysis of sub-30 nm particle sizes. A very high GA loading capacity (3:10 drug/polymer w/w) and sustained drug release were achieved with the optimized telodendrimers. These novel nanoformulations of GA were found to exhibit similar in vitro cytotoxic activity against colon cancer cells as the free drug. Near-infrared fluorescence small animal imaging revealed preferential accumulation of GA-loaded NPs into tumor tissue. The optimized nanoformulation of GA achieved superior antitumor efficacy compared to GA-Cremophor EL formulation at equivalent doses in HT-29 human colon cancer xenograft mouse models. Given the mild adverse effects associated with this natural compound and the enhanced anticancer effects via tumor targeted telodendrimer delivery, the optimized GA nanoformulation is a promising alternative to the traditional chemotherapy in colon cancer treatment.
AuthorsWenzhe Huang, Xu Wang, Changying Shi, Dandan Guo, Gaofei Xu, Lili Wang, Alexa Bodman, Juntao Luo
JournalMolecular pharmaceutics (Mol Pharm) Vol. 12 Issue 4 Pg. 1216-29 (Apr 06 2015) ISSN: 1543-8392 [Electronic] United States
PMID25692376 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Dendrimers
  • Drug Carriers
  • Micelles
  • Xanthones
  • Vitamin E
  • Polyethylene Glycols
  • gambogic acid
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • Cell Line, Tumor
  • Colonic Neoplasms (drug therapy)
  • Dendrimers (chemistry)
  • Drug Carriers (therapeutic use)
  • Drug Delivery Systems
  • Drug Design
  • Female
  • HCT116 Cells
  • Hemolysis
  • Humans
  • Light
  • MCF-7 Cells
  • Mice
  • Mice, Nude
  • Micelles
  • Microscopy, Confocal
  • Microscopy, Electron, Transmission
  • Nanoparticles (chemistry)
  • Neoplasm Transplantation
  • Polyethylene Glycols (chemistry)
  • Scattering, Radiation
  • Solubility
  • Vitamin E (chemistry)
  • Xanthones (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: